MiR-34a is Involved in the Decrease of ATP Contents Induced by Resistin Through Target on ATP5S in HepG2 Cells

Biochemical Genetics

Volumn 53, Issue 11-12, 2015, Pages 301-309

  Wen, Fengyun ^a   Li, Bin ^b   Huang, Chunyan ^b   Wei, Zhiguo ^a   Zhou, Yingying ^a   Liu, Jianyu ^a   Zhang, Haiwei ^a  

^a HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

ATP contents; ATP5S; miR 34a; Resistin

Indexed keywords

ADENOSINE TRIPHOSPHATE; ATP5S PROTEIN; MICRORNA 34A; PROTEIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; RESISTIN; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; ATP5S PROTEIN, HUMAN; MESSENGER RNA; MICRORNA; MIRN34 MICRORNA, HUMAN; RETN PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; BHK CELL LINE; BIOINFORMATICS; CONTROLLED STUDY; GENE OVEREXPRESSION; HEPG2 CELL LINE; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; TRANSIENT TRANSFECTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; CELL LINE; LIVER CELL; MESOCRICETUS; METABOLISM; MICROARRAY ANALYSIS;

3' UNTRANSLATED REGIONS; ADENOSINE TRIPHOSPHATE; ANIMALS; CELL LINE; HEP G2 CELLS; HEPATOCYTES; HUMANS; MESOCRICETUS; MICE; MICROARRAY ANALYSIS; MICRORNAS; MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES; RESISTIN; RNA, MESSENGER;

EID: 84947045926     PISSN: 00062928     EISSN: 15734927     Source Type: Journal    
DOI: 10.1007/s10528-015-9693-x     Document Type: Article

References (30)

1. Abate N, Sallam HS, Rizzo M, Nikolic D, Obradovic M, Bjelogrlic P, Isenovic ER (2014) Resistin: an inflammatory cytokine Role in cardiovascular diseases, diabetes and the metabolic syndrome. Curr Pharm Des 20(31):4961–4969
2. Banerjee RR, Rangwala SM, Shapiro JS, Rich AS, Rhoades B, Qi Y, Wang J, Rajala MW, Pocai A, Scherer PE et al (2004) Regulation of fasted blood glucose by resistin. Science 303(5661):1195–1198
3. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136(2):215–233
4. Cui Q, Yu Z, Purisima EO, Wang E (2007) MicroRNA regulation and interspecific variation of gene expression. Trends Genet 23(8):372–375
5. Dang LT, Lawson ND, Fish JE (2013) MicroRNA control of vascular endothelial growth factor signaling output during vascular development. Arterioscler Thromb Vasc Biol 33(2):193–200
6. Edwards CR, Hindle AK, Latham PS, Fu SW, Brody FJ (2013) Resistin expression correlates with steatohepatitis in morbidly obese patients. Surg Endosc 27(4):1310–1314
7. Fargnoli JL, Sun Q, Olenczuk D, Qi L, Zhu Y, Hu FB, Mantzoros CS (2010) Resistin is associated with biomarkers of inflammation while total and high-molecular weight adiponectin are associated with biomarkers of inflammation, insulin resistance, and endothelial function. Eur J Endocrinol 162(2):281–288
8. Greco D, Gambina F, Pisciotta M, Abrignani M, Maggio F (2012) Clinical characteristics and associated comorbidities in diabetic patients with cranial nerve palsies. J Endocrinol Invest 35(2):146–149
9. Houstek J, Andersson U, Tvrdik P, Nedergaard J, Cannon B (1995) The expression of subunit c correlates with and thus may limit the biosynthesis of the mitochondrial F0F1-ATPase in brown adipose tissue. J Biol Chem 270(13):7689–7694
10. Jamaluddin MS, Weakley SM, Yao Q, Chen C (2012) Resistin: functional roles and therapeutic considerations for cardiovascular disease. Br J Pharmacol 165(3):622–632
11. Johnson CD, Esquela-Kerscher A, Stefani G, Byrom M, Kelnar K, Ovcharenko D, Wilson M, Wang X, Shelton J, Shingara J et al (2007) The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res 67(16):7713–7722
12. Kim KH, Lee K, Moon YS, Sul HS (2001) A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 276(14):11252–11256
13. Kocamis H, Hossain M, Cinar MU, Salilew-Wondim D, Mohammadi-Sangcheshmeh A, Tesfaye D, Holker M, Schellander K (2013) Expression of microRNA and microRNA processing machinery genes during early quail (Coturnix japonica) embryo development. Poult Sci 92(3):787–797
14. Kuehbacher A, Urbich C, Dimmeler S (2008) Targeting microRNA expression to regulate angiogenesis. Trends Pharmacol Sci 29(1):12–15
15. Kuhnert F, Mancuso MR, Hampton J, Stankunas K, Asano T, Chen CZ, Kuo CJ (2008) Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126. Development 135(24):3989–3993
16. Lee SE, Kim HS (2012) Human resistin in cardiovascular disease. J Smooth Muscle Res 48(1):27–35
17. Li M, Yu M, Liu C, Zhu H, He X, Peng S, Hua J (2013) miR-34c works downstream of p53 leading to dairy goat male germline stem-cell (mGSCs) apoptosis. Cell Prolif 46(2):223–231
18. Luo Z, Zhang Y, Li F, He J, Ding H, Yan L, Cheng H (2009) Resistin induces insulin resistance by both AMPK-dependent and AMPK-independent mechanisms in HepG2 cells. Endocrine 36(1):60–69
19. Mallory AC, Vaucheret H (2004) MicroRNAs: something important between the genes. Curr Opin Plant Biol 7(2):120–125
20. Miko E, Margitai Z, Czimmerer Z, Varkonyi I, Dezso B, Lanyi A, Bacso Z, Scholtz B (2011) miR-126 inhibits proliferation of small cell lung cancer cells by targeting SLC7A5. FEBS Lett 585(8):1191–1196
21. Muse ED, Feldman DI, Blaha MJ, Dardari ZA, Blumenthal RS, Budoff MJ, Nasir K, Criqui MH, Cushman M, McClelland RL et al (2015) The association of resistin with cardiovascular disease in the multi-ethnic study of atherosclerosis. Atherosclerosis 239(1):101–108
22. Pirvulescu M, Manduteanu I, Gan AM, Stan D, Simion V, Butoi E, Calin M, Simionescu M (2012) A novel pro-inflammatory mechanism of action of resistin in human endothelial cells: up-regulation of SOCS3 expression through STAT3 activation. Biochem Biophys Res Commun 422(2):321–326
23. Qi L, Hongjuan H, Ning G, Zhengbin H, Yanjiang X, Tiebo Z, Zhijun H, Qiong W (2013) miR-370 is stage-specifically expressed during mouse embryonic development and regulates Dnmt3a. FEBS Lett 587(6):775–781
24. Sadashiv ST (2012) Over expression of resistin in adipose tissue of the obese induces insulin resistance. World J Diabetes 3(7):135
25. Sanadi DR, Pringle M, Kantham L, Hughes JB, Srivastava A (1984) Evidence for the involvement of coupling factor B in the H+ channel of the mitochondrial H+-ATPase. Proc Natl Acad Sci USA 81(5):1371–1374
26. Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV, O’Rahilly S (2001) Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes 50(10):2199–2202
27. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA (2001) The hormone resistin links obesity to diabetes. Nature 409(6818):307–312
28. Valsamakis G, McTernan PG, Chetty R, Al Daghri N, Field A, Hanif W, Barnett AH, Kumar S (2004) Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines. Metabolism 53(4):430–434
29. Vendrell J, Broch M, Vilarrasa N, Molina A, Gomez JM, Gutierrez C, Simon I, Soler J, Richart C (2004) Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes Res 12(6):962–971
30. Zhou L, Yu X, Meng Q, Li H, Niu C, Jiang Y, Cai Y, Li M, Li Q, An C et al (2013) Resistin reduces mitochondria and induces hepatic steatosis in mice by the protein kinase C/protein kinase G/p65/PPAR gamma coactivator 1 alpha pathway. Hepatology 57(4):1384–1393